Travere Therapeutic (TVTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist

18.180
-0.070-0.38%

Close Nov 25 16:00 ET

18.190
+0.010+0.06%

Post 18:34 ET

1.58BMarket Cap-3969P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025
Seeking Alpha15:10 ET
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Seeking Alpha13:58 ET
Travere Therapeutics (TVTX) Gets a Buy From J.P. Morgan
TipRanksNov 21 07:05 ET · Ratings
Express News | Travere Therapeutics Inc : JP Morgan Cuts Target Price to $42 From $43
ReutersNov 20 00:28 ET
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Seeking AlphaNov 19 11:06 ET
Travere Therapeutics Is Maintained at Neutral by Piper Sandler
Dow JonesNov 14 09:28 ET · Ratings

Comments

Jaguar8

Nov 4 13:02

NEWS 13G

$Travere Therapeutic (TVTX.US)$
Travere Therapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.02%)

Stock_Drift

Oct 26 08:40

Earnings on 10/31 👻🎃

$Travere Therapeutic (TVTX.US)$

MMu

Oct 17 13:03

$Travere Therapeutic (TVTX.US)$ They got the europe approval as well! When is the next event date? @anyone

MMu

Oct 14 14:06

$Travere Therapeutic (TVTX.US)$
Someone buying large blocks 150k, 50k....
Does anybody know what's going on?

Jaguar8

Sep 26 15:03

NEWS

$Travere Therapeutic (TVTX.US)$
Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up
SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced a voluntary pause of enrollment in the Phase 3 HARMONY Study evaluating pegtibatinase for the treatment of classical homocystinuria (HCU). The voluntary enrollment pause enables the Company to work to address ...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

TVTX Travere Therapeutic

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target